Vicore Pharma Holding AB (VCRE) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 9 47 sessions, July 6, 2026 to September 16, 2026
- Largest daily move
- -8.2% close of July 13, 2026
Company Description
Vicore Pharma Holding AB (NASDAQ: VCRE) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $299.8M.
VCRE has declined 17.6% over the past month. The last closing price was $10.65.
This page collects what Stock Titan holds for VCRE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vicore Pharma Holding AB (VCRE) closed at $10.65 on September 16, 2026. Over the past month, the price has lost 17.6%.
VCRE Metrics & Rankings
Price returns through September 16, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Vicore Pharma Holding AB has 6 recent news articles, with the latest published today. Of the recent coverage, 1 article coincided with positive price movement and 3 with negative movement. View all VCRE news →
SEC Filings
Vicore Pharma Holding AB has filed 2 recent SEC filings, including 2 Form 6-K. The most recent filing was submitted on August 21, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VCRE SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Vicore Pharma Holding AB (VCRE) currently stands at 11.7 thousand shares, up 4.9% from the previous reporting period, representing 0.0% of the float. Since July 2026, short interest has decreased by 27.6%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Vicore Pharma Holding AB (VCRE) currently stands at 1.4 days, down 21.5% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has increased 39% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 5.4 days.
VCRE Company Profile & Sector Positioning
Vicore Pharma Holding AB (VCRE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.